SARS-CoV-2 in multiple myeloma Multiple myeloma affects adaptive immunity with neoplastic plasma cells being unable to manufacture the polyclonal immunoglobulins required to fight infections. Additionally, myeloma treatment can raise immunodeficiency, especially during the initial months of treatment or during relapsed disease. In this video, Krina Patel, MD, MSc, MD Anderson Cancer Center, Houston, TX, talks […]

Read More